TrialDiabetes, obesity & metabolism2008

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide.

M Horowitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.